企業プロフィール · Healthcare

Danaher Corporation

DHR · 米国株
取引所
米国株
国 / 地域
USA
上場日
1979年1月5日
従業員数
58,000
公式サイト
www.danaher.com
現在値
$177.17
リアルタイム · 2026年6月18日
ベイリー成長スコア
48/100
やや弱い
本源的価値 · 3 段階レンジ 現在値 $177.17 リアルタイム · 妥当な本源的価値レンジ内

総合バリュエーションレンジ · 保守的 $115–$140 / 妥当 $140–$180 / 楽観的 $205–$230。$177.17 時点で 妥当な本源的価値レンジ内。

レポート公開時 $172(2026年5月25日)

この銘柄のレポートはお使いの言語でまだありません。

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

時価総額$1258.13億
売上高(TTM)$247.78億
EBITDA$79.35億
純利益率14.89%
ROE7.08%
PER (TTM)34.38
予想PER21.05
PEG1.14
EPS$5.17
配当利回り0.75%
52週レンジ$160.93 – $242.28
アナリスト目標株価$242.35
アナリスト評価4.6 / 5

データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。

沿革

近日公開このセクションは現在準備中です。近日公開予定です。

業界での地位

近日公開このセクションは現在準備中です。近日公開予定です。